There is no need for a formal transfer of records, though knowing your current dose and any side effects you have experienced helps the new provider make informed decisions
Retatrutide targets three different receptors: GLP-1 (helps regulate appetite and blood sugar) GIP (supports insulin response) Glucagon (affects energy use and fat metabolism) By targeting all three, the medication delays how fast your stomach digests food, lowers your appetite, and ultimately reduces how much food you eat
This means you burn more calories throughout the day, even during rest
Physicians should avoid prescribing it to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Individuals with severe gastrointestinal conditions, such as gastroparesis. Patients with a known allergy to GLP-1 receptor agonists. Pregnant or breastfeeding women, unless approved by a physician
Start your intake Why Hypothyroidism Resists Standard Weight Loss Approaches Thyroid hormones T3 and T4 directly control basal metabolic rate, thermogenesis, and mitochondrial energy production
automatic eligibility for the program